本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vaxcyte, Inc.

59.47
+0.57000.97%
盤後59.470.00000.00%19:30 EDT
成交量:168.34萬
成交額:9,925.82萬
市值:88.49億
市盈率:-7.77
高:60.20
開:60.07
低:58.21
收:58.90
52周最高:65.00
52周最低:30.81
股本:1.49億
流通股本:1.36億
量比:1.65
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-7.6496
每股收益(LYR):-5.6333
淨資產收益率:-36.51%
總資產收益率:-22.61%
市淨率:3.21
市盈率(LYR):-10.56

資料載入中...

2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/02

重要事件披露

Form 8-K - Current report
2025/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities